TY - JOUR
T1 - Consensus-based care recommendations for adults with myotonic dystrophy type 2
AU - Schoser, Benedikt
AU - Montagnese, Federica
AU - Bassez, Guillaume
AU - Fossati, Barbara
AU - Gamez, Josep
AU - Heatwole, Chad
AU - Hilbert, James
AU - Kornblum, Cornelia
AU - Kostera-Pruszczyk, Anne
AU - Krahe, Ralf
AU - Lusakowska, Anna
AU - Meola, Giovanni
AU - Moxley, Richard
AU - Thornton, Charles
AU - Udd, Bjarne
AU - Formaker, Paul
N1 - Publisher Copyright:
© 2019 American Academy of Neurology.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Purpose of reviewMyotonic dystrophy type 2 (DM2) is a rare, progressive multisystem disease particularly affecting the skeletal muscle. A causal therapy is not yet available; however, prompt, appropriate symptomatic treatments are essential to limit disease-related complications. Evidence-based guidelines to assist medical practitioners in the care of DM2 patients do not exist.Recent findingsThe Myotonic Dystrophy Foundation (MDF) previously worked with an international group of 66 clinicians to develop consensus-based care recommendations for myotonic dystrophy type 1. Following a similar approach, the MDF recruited 15 international clinicians with long-standing experience in the care of DM2 patients to develop consensus-based care recommendations. The single text procedure was adopted. This process generated a 4-page Quick Reference Guide and a comprehensive 55-page document that provides care recommendations for DM2 patients.SummaryThe resulting recommendations will help standardize and improve care for DM2 patients and facilitate appropriate management in centers without neuromuscular specialists.
AB - Purpose of reviewMyotonic dystrophy type 2 (DM2) is a rare, progressive multisystem disease particularly affecting the skeletal muscle. A causal therapy is not yet available; however, prompt, appropriate symptomatic treatments are essential to limit disease-related complications. Evidence-based guidelines to assist medical practitioners in the care of DM2 patients do not exist.Recent findingsThe Myotonic Dystrophy Foundation (MDF) previously worked with an international group of 66 clinicians to develop consensus-based care recommendations for myotonic dystrophy type 1. Following a similar approach, the MDF recruited 15 international clinicians with long-standing experience in the care of DM2 patients to develop consensus-based care recommendations. The single text procedure was adopted. This process generated a 4-page Quick Reference Guide and a comprehensive 55-page document that provides care recommendations for DM2 patients.SummaryThe resulting recommendations will help standardize and improve care for DM2 patients and facilitate appropriate management in centers without neuromuscular specialists.
UR - http://www.scopus.com/inward/record.url?scp=85067851835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067851835&partnerID=8YFLogxK
U2 - 10.1212/CPJ.0000000000000645
DO - 10.1212/CPJ.0000000000000645
M3 - Review article
C2 - 31583190
AN - SCOPUS:85067851835
SN - 2163-0402
VL - 9
SP - 343
EP - 353
JO - Neurology: Clinical Practice
JF - Neurology: Clinical Practice
IS - 4
ER -